These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 934247)

  • 1. Letter: Effects of reperfusion on antiarrhythmic drug activity.
    Ecanow B; Gold BH
    N Engl J Med; 1976 Aug; 295(8):447-8. PubMed ID: 934247
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-arrhythmia agents and their effects on atrioventricular conduction].
    Satoh K; Taira N
    Nihon Rinsho; 1982; 40(11):2392-8. PubMed ID: 7154268
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antiarrhythmic drugs on the A-V conduction in isolated hearts.
    Brusca A; Rosettani E; Favella L
    G Ital Cardiol; 1972; 2(1):158. PubMed ID: 5011998
    [No Abstract]   [Full Text] [Related]  

  • 4. Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.
    Thomas GP; Ferrier GR; Howlett SE
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1090-7. PubMed ID: 8819490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the anti-arrhythmic activity of serpentine and its effect on the heart conduction system].
    Gendenshteĭn EI; Mikhaĭlenko LA
    Farmakol Toksikol; 1965; 28(1):42-6. PubMed ID: 5845040
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):475-80. PubMed ID: 7252847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
    Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
    Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
    Gülker H; Heuer H; Thale J; Behrenbeck T
    Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the effects of disopyramide and procainamide on auriculo-ventricular conduction in dogs under chloralose].
    Duchêne-Marullaz P; Schaff G; Lapalus P; Lautier F; Lavarenne P
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):327-9. PubMed ID: 4249123
    [No Abstract]   [Full Text] [Related]  

  • 12. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy].
    Pastelin G; Cuevas B; Alvarado JL; Méndez R
    Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the electrophysiologic, antiarrhythmic and haemodynamic profile of a new isoquinolinedione derivative.
    Gülker H; Spyra W; Thale J; Krimphove F; Hübner A; Bender F
    Arzneimittelforschung; 1987 Aug; 37(8):917-9. PubMed ID: 3675686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmic agents and atrioventricular conduction].
    Knippel M; Rovelli F
    G Ital Cardiol; 1972; 2(1):184. PubMed ID: 5012012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of several anti-arrhythmia agents on excitability and conduction depressed by digitalis agents].
    Márquez M; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(6):535-44. PubMed ID: 6241458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on heart-lung-preparation of dog. Effect of various antiarrhythmic active substances on the contractility, rate of conductivity, refractory phase and excitability of heart].
    Igarashi T; Shyoji T
    Arzneimittelforschung; 1968 Nov; 18(11):1368-72. PubMed ID: 5755899
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular and antiarrhythmic effects of the azulene-1-carboxamidine derivative N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine.
    Saitoh M; Sugiyama A; Hagihara A; Nakazawa T; Hashimoto K
    Arzneimittelforschung; 1997 Jul; 47(7):810-5. PubMed ID: 9272236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.